Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
84,773,475
-
Share change
-
+8,250,715
-
Total reported value
-
$6,296,721,913
-
Put/Call ratio
-
101%
-
Price per share
-
$74.27
-
Number of holders
-
678
-
Value change
-
+$546,177,580
-
Number of buys
-
354
-
Number of sells
-
285
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q2 2022
As of 30 Jun 2022,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
678 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
84,773,475 shares.
The largest 10 holders included
MORGAN STANLEY, BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, CITIGROUP INC, UBS Group AG, BNP PARIBAS ARBITRAGE, SA, TORONTO DOMINION BANK, Clal Insurance Enterprises Holdings Ltd, Avidity Partners Management LP, and Harel Insurance Investments & Financial Services Ltd..
This page lists
684
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.